Hangzhou Biotest Biotech Co Ltd Class A 688767
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 28.80
- Day Range
- CNY 28.73–29.60
- 52-Week Range
- CNY 22.23–36.70
- Bid/Ask
- CNY 29.05 / CNY 29.08
- Market Cap
- CNY 3.10 Bil
- Volume/Avg
- 318,351 / 487,822
Key Statistics
- Price/Earnings (Normalized)
- 26.75
- Price/Sales
- 6.42
- Dividend Yield (Trailing)
- 7.64%
- Dividend Yield (Forward)
- 7.64%
- Total Yield
- 7.62%
Company Profile
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 629
- Website
- http://www.biotests.com.cn
Comparables
Valuation
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.75 | 23.49 | 13.56 |
Price/Book Value | 1.27 | 2.81 | 0.83 |
Price/Sales | 6.42 | 8.95 | 5.66 |
Price/Cash Flow | 14.63 | 13.56 | 14.55 |
Price/Earnings
688767
688253
688068
Financial Strength
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Quick Ratio | 12.97 | 10.60 | 2.87 |
Current Ratio | 13.60 | 11.04 | 6.20 |
Interest Coverage | — | 1,693.02 | — |
Quick Ratio
688767
688253
688068
Profitability
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Return on Assets (Normalized) | 7.17% | 4.47% | −1.03% |
Return on Equity (Normalized) | 7.61% | 4.81% | −1.10% |
Return on Invested Capital (Normalized) | 7.58% | 4.51% | −1.96% |
Return on Assets
688767
688253
688068
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tycjmdcrch | Qnzw | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Kkhlftqd | Dtycdb | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Pbtxdcm | Lbzgqqx | $106.7 Bil | |
MRNA
| Moderna Inc | Btymdcl | Vgd | $50.8 Bil | |
BNTX
| BioNTech SE ADR | Jgzkqzlh | Kljnd | $22.4 Bil | |
ARGX
| argenx SE ADR | Rfkbsjm | Ctlr | $22.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lxpbmzsr | Cfnsdx | $19.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zdmyxxrs | Pmbkkdn | $14.6 Bil | |
INCY
| Incyte Corp | Fmmddvyj | Jvsqcj | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Qjwszfpkl | Gjcyby | $12.6 Bil |